1-5 of 5
Manuel Gotti, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lenalidomide Maintenance after Autologous Transplantation Prolongs PFS in Young MCL Patients: Results of the Randomized Phase III MCL 0208 Trial from Fondazione Italiana Linfomi (FIL)

Marco Ladetto, Simone Ferrero, MD, Andrea Evangelista, PhD, Michael Mian, MD, Alice Di Rocco, Angela Coggi, Giuseppe Rossi, MD, Alessandro Re, MD, Vittorio Stefoni, Federica Cavallo, MD PhD, Annalisa Chiappella, MD, Armando Santoro, MD, Chiara Rusconi, Maria Gomes da Silva, MD, Manuel Gotti, MD, Anna Lia Molinari, MD, Filippo Ballerini, MD, Andres J M Ferreri, MD, Alberto Bosi, MD, Franco Narni, MD, Caterina Stelitano, MD, Alberto Zamò, MD, Gianni Ciccone, Umberto Vitolo, Maurizio Martelli, Sergio Cortelazzo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 401.
https://doi.org/10.1182/blood-2018-99-110289
Published: 2018
Journal Articles

Five-Year Survival and Durability Results of the Phase 2 Trial Using the Begev Regimen (Bendamustine, Gemcitabine And Vinorelbine)As Salvage Therapy Prior to Autologous Stem Cell Transplant for Relapsed/Refractory Classic Hodgkin Lymphoma

Armando Santoro, MD, Rita Mazza, MD, Alessandro Pulsoni, MD, Alessandro Re, MD, Maurizio Bonfichi, MD, Vittorio Ruggero Zilioli, Flavia Salvi, Antonella Anastasia, MD, Stefano Luminari, MD, Manuel Gotti, MD, Annalisa Peli, MD, Anna Marina Liberati, MD, Nicola Di Renzo, MD, Luca Castagna, MD, Laura Giordano, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1628.
https://doi.org/10.1182/blood-2018-99-118931
Published: 2018
Journal Articles

Rituximab, Bendamustine and Cytarabine (RBAC500) As Induction Therapy in Elderly Patients with Mantle Cell Lymphoma: Final Results of a Phase 2 Study from the Fondazione Italiana Linfomi

Carlo Visco, MD, Annalisa Chiappella, MD, Luca Nassi, Caterina Patti, MD, Simone Ferrero, Daniela Barbero, Andrea Evangelista, Michele Spina, Anna Lia Molinari, Luigi Rigacci, Monica Tani, Alice Di Rocco, MD PhD, Graziella Pinotti, Alberto Fabbri, MD, Renato Zambello, Silvia Finotto, MD, Manuel Gotti, MD, Angelo Michele Carella, Flavia Salvi, Stefano A Pileri, Marco Ladetto, MD, Giovannino Ciccone, MD PhD, Gianluca Gaidano, Marco Ruggeri, MD, Maurizio Martelli, Umberto Vitolo, MD
Journal: Blood
Blood (2016) 128 (22): 472.
https://doi.org/10.1182/blood.V128.22.472.472
Published: 2016
Journal Articles

Remarkable Clinical Efficacy, Stem Cell Mobilization Activity and Good Toxicity Profile of the Novel Begev Regimen (Bendamustine, Gemcitabine And Vinorelbine) Used As Salvage Therapy Prior to Autologous Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

Armando Santoro, MD, Rita Mazza, MD, Alessandro Pulsoni, MD, Alessandro Re, Maurizio Bonfichi, MD, Vittorio Ruggero Zilioli, MD, Flavia Salvi, MD, Antonella Anastasia, Stefano Luminari, MD, Manuel Gotti, MD, Annalisa Peli, Anna Marina Liberati, MD, Nicola Di Renzo, Luca Castagna, Laura Giordano, Carmelo Carlo-Stella, MD
Journal: Blood
Blood (2015) 126 (23): 581.
https://doi.org/10.1182/blood.V126.23.581.581
Published: 2015
Journal Articles

Outcome of Transformed Marginal Zone Lymphomas Treated in the Rituximab Era

Chiara Rusconi, MD, Maria Luisa Guerrera, MD, Alessandra Tedeschi, MD, Michelle Zancanella, MD, Manuel Gotti, MD, Michele Nichelatti, Sara Rattotti, MD, Lara Crucitti, MD, Marco Frigeni, Erika Meli, MD, Paola Picardi, MD, Anna Maria Frustaci, MD, Roberta Sciarra, Vittorio Ruggero Zilioli, MD, Periana Minga, MD, Marco Paulli, Roberto Cairoli, MD, Luca Arcaini
Journal: Blood
Blood (2015) 126 (23): 5098.
https://doi.org/10.1182/blood.V126.23.5098.5098
Published: 2015